This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Institut Pasteur. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Olivier Schwartz: Innovator in Glycosyl Phospholipid Derivatives
Introduction
Olivier Schwartz is a notable inventor based in Paris, France. He has made significant contributions to the field of biochemistry, particularly through his innovative work on glycosyl phospholipid derivatives of nucleosides. His research has implications for various applications in medicine and pharmacology.
Latest Patents
Olivier Schwartz holds a patent for glycosyl phospholipid derivatives of nucleosides. This patent is based on a specific formula that includes nucleoside derivatives such as 3'-azidothymidine (AZT), 2', 3'-dideoxythymidine (ddT), and 2'-deoxy-5-fluorouridine (dFU). His work in this area represents a significant advancement in the development of therapeutic agents.
Career Highlights
Schwartz is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work at this renowned institution has allowed him to explore innovative solutions in the field of biochemistry and contribute to scientific knowledge.
Collaborations
Olivier Schwartz has collaborated with esteemed colleagues such as Tam Huynh Dinh and Jean Igolen. These partnerships have fostered a collaborative environment that enhances the research output and innovation at the Institut Pasteur.
Conclusion
Olivier Schwartz is a prominent figure in the field of biochemistry, with a focus on glycosyl phospholipid derivatives of nucleosides. His contributions through patents and collaborations highlight his commitment to advancing scientific research and innovation.